139 related articles for article (PubMed ID: 17409099)
21. Runt-Related Transcription Factor 2 (Runx2) Is Responsible for Galectin-3 Overexpression in Human Thyroid Carcinoma.
Kaptan E; Sancar Bas S; Sancakli A; Aktas HG; Bayrak BB; Yanardag R; Bolkent S
J Cell Biochem; 2017 Nov; 118(11):3911-3919. PubMed ID: 28390192
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel DNA regulatory element in the rabbit surfactant protein B (SP-B) promoter that is a target for ATF/CREB and AP-1 transcription factors.
Berhane K; Boggaram V
Gene; 2001 May; 268(1-2):141-51. PubMed ID: 11368910
[TBL] [Abstract][Full Text] [Related]
23. Study of gene expression in thyrotropin-stimulated thyroid cells by cDNA expression array: ID3 transcription modulating factor as an early response protein and tumor marker in thyroid carcinomas.
Deleu S; Savonet V; Behrends J; Dumont JE; Maenhaut C
Exp Cell Res; 2002 Sep; 279(1):62-70. PubMed ID: 12213214
[TBL] [Abstract][Full Text] [Related]
24. Differential binding of cAMP-responsive-element (CRE)-binding protein-1 and activating transcription factor-2 to a CRE-like element in the human tissue-type plasminogen activator (t-PA) gene promoter correlates with opposite regulation of t-PA by phorbol ester in HT-1080 and HeLa cells.
Costa M; Medcalf RL
Eur J Biochem; 1996 May; 237(3):532-8. PubMed ID: 8647095
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site.
Nakamura T; Okuyama S; Okamoto S; Nakajima T; Sekiya S; Oda K
Exp Cell Res; 1995 Feb; 216(2):422-30. PubMed ID: 7843287
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
Recio JA; Merlino G
Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
[TBL] [Abstract][Full Text] [Related]
27. Identification of targets of Twist1 transcription factor in thyroid cancer cells.
Di Maro G; Orlandella FM; Bencivenga TC; Salerno P; Ugolini C; Basolo F; Maestro R; Salvatore G
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1617-26. PubMed ID: 24848707
[TBL] [Abstract][Full Text] [Related]
28. Responsive site on the thrombospondin-1 promotor to down-regulation by phorbol 12-myristate 13-acetate in porcine aortic endothelial cells.
Kim SA; Hong KJ
Exp Mol Med; 2000 Sep; 32(3):135-40. PubMed ID: 11048644
[TBL] [Abstract][Full Text] [Related]
29. Leptin augments recruitment of IRF-1 and CREB to thrombospondin-1 gene promoter in vascular smooth muscle cells in vitro.
Sahu S; Ganguly R; Raman P
Am J Physiol Cell Physiol; 2016 Aug; 311(2):C212-24. PubMed ID: 27281481
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid.
Scarpino S; Cancellario d'Alena F; Di Napoli A; Pasquini A; Marzullo A; Ruco LP
J Pathol; 2004 Mar; 202(3):352-8. PubMed ID: 14991901
[TBL] [Abstract][Full Text] [Related]
31. Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R.
Groussin L; Massias JF; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2000 Jan; 85(1):345-54. PubMed ID: 10634409
[TBL] [Abstract][Full Text] [Related]
32. The concerted regulatory functions of the transcription factors nuclear factor-1 and upstream stimulatory factor on a composite element in the promoter of the hepatocyte growth factor gene.
Jiang JG; Gao B; Zarnegar R
Oncogene; 2000 May; 19(23):2786-90. PubMed ID: 10851080
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells.
Lee KH; Koh SA; Kim JR
Oncol Res; 2013; 20(9):393-402. PubMed ID: 23924923
[TBL] [Abstract][Full Text] [Related]
34. Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells.
El Btaouri H; Morjani H; Greffe Y; Charpentier E; Martiny L
Biochim Biophys Acta; 2011 May; 1813(5):695-703. PubMed ID: 21333695
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid.
Scarpino S; Stoppacciaro A; Colarossi C; Cancellario F; Marzullo A; Marchesi M; Biffoni M; Comoglio PM; Prat M; Ruco LP
J Pathol; 1999 Dec; 189(4):570-5. PubMed ID: 10629560
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
37. The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter.
Jiang JG; DeFrances MC; Machen J; Johnson C; Zarnegar R
Biochem Biophys Res Commun; 2000 Jun; 272(3):882-6. PubMed ID: 10860846
[TBL] [Abstract][Full Text] [Related]
38. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
Moon Y; Bottone FG; McEntee MF; Eling TE
Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
Wang Z; Zhang H; Zhang P; Dong W; He L
Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
[TBL] [Abstract][Full Text] [Related]
40. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
